Case Report: Identification of a novel STAT3 mutation in EBV-positive inflammatory follicular dendritic cell sarcoma
Frontiers in Oncology · 26.10.2023 · 13
DOI: 10.3389/fonc.2023.1266897 ↗Kurz gefasst
Fallbericht in der Zeitschrift Frontiers in Oncology, online erschienen am 26.10.2023. Verfasst von Megan C Ramsey und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hematopathology Department, Toronto General Hospital, Toronto, ON, Canada. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
EBV-positive inflammatory follicular dendritic cell sarcoma (EBV+ IFDCS) is an uncommon disease primarily observed in Asia. It is characterized by the development of tumors believed to originate from follicular dendritic cells (FDC). The consistent association between this condition and clonal EBV infection suggests EBV’s involvement as an etiological factor. However, diagnosing EBV+ IFDCS can be challenging due to its morphological variability and diverse immunohistochemical staining patterns. The genetic characteristics of EBV+ IFDCS remain insufficiently understood. To address this knowledge gap, we present a case study of a 47-year-old male patient diagnosed with EBV+ IFDCS. We utilized a Next-generation sequencing (NGS) platform to investigate the genetic profile of the tumor cells. We identified a single pathogenic mutation (G618R) in the STAT3 gene. This finding provides valuable insights into the genetic alterations associated with EBV+ IFDCS and potentially contributes to our understanding of the disease’s pathogenesis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hematopathology Department, Toronto General Hospital, Toronto, ON, Canada.
- Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
- Division of Clinical Laboratory Genetics, Laboratory Medicine Program, University Health Network, Toronto, ON, Canada.
- Advanced Molecular Diagnostic Laboratory, Princess Margaret Cancer Centre, Toronto, ON, Canada.
- Medical Oncology, Mount Sinai Hospital, Toronto, ON, Canada.
- Joint Department of Medical Imaging, Mount Sinai Hospital, Toronto, ON, Canada.
Zitieren
APA
Ramsey, M. C., Sabatini, P. J. B., Watson, G., Chawla, T., Ko, M., & Sakhdari, A. (2023). Case Report: Identification of a novel STAT3 mutation in EBV-positive inflammatory follicular dendritic cell sarcoma. Frontiers in Oncology, 13. https://doi.org/10.3389/fonc.2023.1266897
Vancouver
Ramsey MC, Sabatini PJB, Watson G, Chawla T, Ko M, Sakhdari A. Case Report: Identification of a novel STAT3 mutation in EBV-positive inflammatory follicular dendritic cell sarcoma. Frontiers in Oncology. 2023;13. doi:10.3389/fonc.2023.1266897
BibTeX
@article{Ramsey2023,
author = {Ramsey, Megan C and Sabatini, Peter J B and Watson, Geoffrey and Chawla, Tanya and Ko, Michael and Sakhdari, Ali},
title = {Case Report: Identification of a novel STAT3 mutation in EBV-positive inflammatory follicular dendritic cell sarcoma},
journal = {Frontiers in Oncology},
year = {2023},
volume = {13},
doi = {10.3389/fonc.2023.1266897}
}
EUVIMED